LEUPROLIDE ACETATE — all Canadian products
16 DINs
12 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is LEUPROLIDE ACETATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02268892 | ELIGARD | TOLMAR INTERNATIONAL LTD. | Powder For Suspension (Sustained-Release | Subcutaneous | LEUPROLIDE ACETATE 45 MG | Marketed | |
| 02248239 | ELIGARD | TOLMAR INTERNATIONAL LTD. | Powder For Suspension (Sustained-Release | Subcutaneous | LEUPROLIDE ACETATE 7.5 MG | Marketed | |
| 02248240 | ELIGARD | TOLMAR INTERNATIONAL LTD. | Powder For Suspension (Sustained-Release | Subcutaneous | LEUPROLIDE ACETATE 22.5 MG | Marketed | |
| 02248999 | ELIGARD | TOLMAR INTERNATIONAL LTD. | Powder For Suspension (Sustained-Release | Subcutaneous | LEUPROLIDE ACETATE 30 MG | Marketed | |
| 00884502 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | Intramuscular | LEUPROLIDE ACETATE 3.75 MG | Marketed | |
| 02562855 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | Intramuscular | LEUPROLIDE ACETATE 45 MG | Marketed | |
| 02239833 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | Intramuscular | LEUPROLIDE ACETATE 30 MG | Marketed | |
| 02239834 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | Intramuscular | LEUPROLIDE ACETATE 11.25 MG | Marketed | |
| 02230248 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | Intramuscular | LEUPROLIDE ACETATE 22.5 MG | Marketed | |
| 00836273 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | Intramuscular | LEUPROLIDE ACETATE 7.5 MG | Marketed | |
| 02429977 | ZEULIDE DEPOT | VERITY PHARMACEUTICALS INC. | Kit; Powder For Suspension (Sustained-Release | Intramuscular | LEUPROLIDE ACETATE 3.75 MG | Marketed | |
| 02462699 | ZEULIDE DEPOT | VERITY PHARMACEUTICALS INC. | Kit; Powder For Suspension (Sustained-Release | Intramuscular | LEUPROLIDE ACETATE 22.5 MG | Marketed | |
| 02240264 | LEUPROLIDE ACETATE INJECTION | NOVOPHARM LIMITED | Liquid | Subcutaneous | LEUPROLIDE ACETATE 5 MG | Cancelled Pre Market | |
| 00727695 | LUPRON | ABBVIE CORPORATION | Solution | Subcutaneous | LEUPROLIDE ACETATE 5 MG | Cancelled Post Market | |
| 02148730 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | Intramuscular | LEUPROLIDE ACETATE 15 MG | Cancelled Pre Market | |
| 02148722 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | Intramuscular | LEUPROLIDE ACETATE 11.25 MG | Cancelled Pre Market |
Browse other molecules: